Transferrin Receptor Protein 1 / CD71 (TFRC) Antibody

Este producto es parte de TFRC - Transferrin Receptor
Product Graph
299€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Transferrin Receptor Protein 1 / CD71 (TFRC) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx101928
tested applications
WB, IHC, IF/ICC

Description

Polyclonal Antibody to Transferrin Receptor (TFR).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Transferrin Receptor Protein 1 / CD71 (TFRC)
Host
Rabbit
Reactivity
Pig
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
CD71,IMD46,T9,TFR,TFR1,TR,TRFR,p90
Background
Antibody anti-TFRC
Status
RUO

Descripción

TFRC, also known as CD71, is a transmembrane glycoprotein that mediates the uptake of transferrin-bound iron into cells via receptor-mediated endocytosis. It plays a crucial role in iron homeostasis, as iron is essential for processes like DNA synthesis, oxygen transport, and energy metabolism. TFRC expression is tightly regulated by cellular iron levels, proliferative demand, and hypoxia, with high expression observed in rapidly dividing cells, such as activated lymphocytes, erythroid progenitors, and cancer cells. Its overexpression is frequently observed in tumors, where increased iron uptake supports cancer cell proliferation and survival. TFRC is also involved in immune regulation and erythropoiesis, with its deficiency leading to anemia, impaired cell growth, and compromised immune responses. Targeting TFRC is being explored in cancer therapy as a mechanism for selective drug delivery and iron deprivation. Knockdown studies show impaired iron metabolism, reduced cell proliferation, and increased sensitivity to oxidative stress, emphasizing its central role in cellular growth, iron transport, and metabolic regulation.

Related Products

FNab01497

anti- CD71 antibody

CD71, also known as transferrin receptor protein 1(TfR1), is a transmembrane glycoprotein composed of two disulfide-linked monomers, each of 90 kDa molecular weight. Each monomer binds one holo-transferrin molecule creating an iron-Tf-TfR complex which enters the cell by endocytosis. CD71 is present on actively proliferating cells and is essential for iron transport into proliferating cells.

Ver Producto
abx004502

Transferrin Receptor Protein 1 / CD71 (TFRC) Antibody

Transferrin Receptor Protein 1 / CD71 (TFRC) Antibody is a Rabbit Polyclonal antibody against Transferrin Receptor Protein 1 / CD71 (TFRC).

Ver Producto
abx021480

Transferrin Receptor Protein 1 / CD71 (TFRC) Antibody

CD71 Transferrin Receptor Antibody is a Mouse monoclonal antibody for human cds against CD71 Transferrin Receptor.

Ver Producto